|
Delayed
London S.E.
15:33:05 04/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 7.166 GBX | -4.45% |
|
-7.54% | -39.01% |
| 07-13 | Oil rises as Iran escalation keeps FTSE subdued | AN |
| 07-13 | Ixico notes ending of Huntington's disease programmes | AN |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 22.14M | - | ||||
| 50.35B | |||||
| 45.2B | - | - | - | - | - |
| 44.71B | |||||
| 41.24B | |||||
| 33.08B |
- Stock Market
- Stocks
- IXI Stock
- Charts IXICO plc
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
